Drug Approval & Regulatory Documents

DISCLOSURE  

The documents in this section relate to the approval by FDA of Lariam® (mefloquine) and to certain regulatory issues. The documents were obtained under the Freedom of Information Act and are published as a public service. Any questions about these documents should be addressed to FDA or to the author(s).